ArticleFrontiers in medicine2025
Establishing a nomogram for post-hepatectomy liver failure prediction in hepatocellular carcinoma based on pre-operative and perioperative parameters.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of Liver Function in the Multiparametric Assessment of Hepatocellular Carcinoma.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Post-hepatectomy liver failure (PHLF) is a severe complication for hepatocellular carcinoma (HCC) patients post-surgery. This study explores PHLF risk factors and creates a nomogram for prediction using pre- and intraoperative factors. Methods: We retrospectively analyzed 654 patients who underwent hepatectomy. Eligible patients were randomly divided into training and internal validation cohorts in a 7:3 ratio. Key variables for nomogram construction were determined through integrated Least Absolute Shrinkage and Selection Operator (LASSO) and multivariate logistic regression analyses. The nomogram's performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis. Results: Among 228 eligible patients included in the study, 55 developed PHLF. Seven independent predictors were identified and incorporated into the nomogram: liver cirrhosis, total bilirubin (TBIL), prothrombin time (PT), Albumin-Bilirubin (ALBI), fibrosis-4 index (FIB4), ascites, and intraoperative blood loss. The nomogram demonstrated excellent predictive performance, with area under the curve (AUC) of 0.880 in the training cohort and 0.879 in the validation cohort. Calibration curve and decision curve analysis show that nomogram has significant clinical application value in predicting PHLF probability. Conclusion: We have developed and validated a novel PHLF risk prediction model that integrates pre-operative and intraoperative parameters, along with various liver function scoring systems, enabling more comprehensive and accurate prediction of PHLF risk in HCC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.